Cardiology CE Mark Structural Heart

Europe allows Edwards’ Sapien 3 TAVR system in low-risk patients

Released on November 6, 2019

Dive Brief: Edwards Lifesciences’ Sapien 3 transcatheter heart valve is now allowed for use in Europe in patients at low risk […]

Read more
Cardiology Structural Heart

Boston Sci Gives Update on the Measured Launch of Lotus Edge

Released on October 28, 2019

Boston Scientific’s Lotus Edge might be one of the biggest and most significant FDA approvals of 2019. However, Boston Scientific has […]

Read more
Cardiology Structural Heart

TAVR momentum lifts Edwards’ Q3 results, beating estimates

Released on October 25, 2019

Dive Brief: Edwards Lifesciences credited strong clinical trial results from its Partner 3 study, which supported an expanded FDA indication in August for […]

Read more
Cardiology Structural Heart

TAVR momentum lifts Edwards’ Q3 results, beating estimates

Released on October 24, 2019

Dive Brief: Edwards Lifesciences credited strong clinical trial results from its Partner 3 study, which supported an expanded FDA indication in August […]

Read more
Cardiology Orthopedic Structural Heart

The top 10 medical disruptors of 2020

Released on October 24, 2019

For the past 17 years, the Cleveland Clinic has predicted what the top 10 medical disruptors will be for the following […]

Read more
Cardiology Structural Heart

Edwards jumps on Q3 sales & earnings beat, raised outlook

Released on October 24, 2019

Edwards Lifesciences (NYSE:EW) shares jumped after hours today on third-quarter results that topped the consensus forecast. The Irvine, Calif.-based heart valve replacement […]

Read more
Cardiology Structural Heart

VEST external stent demonstrates low event and disease rates in two prospective trials

Released on October 18, 2019

Clinical data presented at the 2019 European Cardio-Thoracic Surgery (EACTS) annual meeting (3-5 October, Lisbon, Portugal), from two prospective trials of […]

Read more
FDA Structural Heart

Medtronic Launches Evolut Pro+ TAVR System: Interview with Dr. Pieter Kappetein

Released on October 15, 2019

Last month, Medtronic announced receipt of U.S. Food and Drug Administration (FDA) approval for and launch of the Evolut Pro+ TAVR […]

Read more
Funding Structural Heart

Edwards Lifesciences to put $100m into Costa Rica expansion

Released on October 14, 2019

Edwards Lifesciences (NYSE:EW) is slated to add a $100 million expansion and 500 new jobs by the end of 2020 in an […]

Read more
Funding Structural Heart

Valfix Medical pulls in $1m for dual heart valve repair-replacement device

Released on October 14, 2019

Valfix Medical this week filed an SEC Form D reporting that it sold more than $1 million in an equity offering. The […]

Read more
Cardiology Funding Structural Heart

4C Medical pulls in $8m

Released on October 3, 2019

4C Medical Technologies secured more than $8 million in an equity offering it hopes will reach the $20 million mark. The Maple […]

Read more
Structural Heart

Edwards SAPIEN 3 TAVR Demonstrates Significant Health Status Improvements for Low-Risk Patients

Released on September 30, 2019

SAN FRANCISCO, Sept. 29, 2019 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care […]

Read more